梅花生物(600873.SH)：前三季度净利润30.25亿元，同比增长51.61%

Core Viewpoint - Meihua Biological (600873.SH) reported a decline in total operating revenue for the first three quarters of 2025, while net profit attributable to shareholders saw significant growth [1] Financial Performance - Total operating revenue for the first three quarters of 2025 reached 18.215 billion yuan, a year-on-year decrease of 2.49% [1] - Net profit attributable to shareholders was 3.025 billion yuan, reflecting a year-on-year increase of 51.61% [1] - Basic earnings per share stood at 1.06 yuan [1]